1-20 of 32
Authors: Ella Ariza-Heredia
Sort by
Journal Article
Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma: A 7-Year Retrospective Cohort Study
Tali Shafat and others
Open Forum Infectious Diseases, Volume 12, Issue 4, April 2025, ofaf127, https://doi.org/10.1093/ofid/ofaf127
Published: 04 March 2025
Journal Article
P-694. Outcomes of respiratory viral infections in hematopoietic cell transplant recipients and patients with leukemia: a prospective study
Georgios Angelidakis and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.890, https://doi.org/10.1093/ofid/ofae631.890
Published: 29 January 2025
Journal Article
P-726. "Infectious Complications in Patients with Relapsed/Refractory Multiple Myeloma Undergoing Novel Bispecific Antibody Therapy: A Myeloma-Infectious Disease Database Initiative"
Silpa Jetty and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.922, https://doi.org/10.1093/ofid/ofae631.922
Published: 29 January 2025
Journal Article
P-1094. Real-World Experience with Maribavir for the Treatment of Cytomegalovirus Infection in Patients with Hematologic Malignancies
Marilyne Daher and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.1282, https://doi.org/10.1093/ofid/ofae631.1282
Published: 29 January 2025
Journal Article
632. Cytomegalovirus Infections in Patients with Relapsed/Refractory Multiple Myeloma on Novel T-Cell Redirecting Therapy
Jennifer Makhoul and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.197, https://doi.org/10.1093/ofid/ofae631.197
Published: 29 January 2025
Journal Article
P-1013. Incidence and Risk Factors for Fungal Infection after CD19-targeted Chimeric Antigen Receptor T cell Therapy for Non-Hodgkin Lymphoma
Charles Gaulin and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.1203, https://doi.org/10.1093/ofid/ofae631.1203
Published: 29 January 2025
Journal Article
P-730. Risk Factors for Severe Influenza and Respiratory Syncytial Virus Infections in Patients with Lymphoma or Multiple Myeloma - A Seven-Year Retrospective Cohort Study
Tali Shafat and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.926, https://doi.org/10.1093/ofid/ofae631.926
Published: 29 January 2025
Journal Article
P-729. Prognostic Value of the Immunodeficiency Scoring Index for Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients
Tali Shafat and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.925, https://doi.org/10.1093/ofid/ofae631.925
Published: 29 January 2025
Journal Article
P-2297. Evaluation of a Meta-Virus Signature as a Diagnostic Tool to Predict the Severity of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients
Tali Shafat and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.2450, https://doi.org/10.1093/ofid/ofae631.2450
Published: 29 January 2025
Journal Article
1995. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes
Anthony J Febres-Aldana and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.122, https://doi.org/10.1093/ofid/ofad500.122
Published: 27 November 2023
Journal Article
Respiratory Viral Infections in Recipients of Cellular Therapies: A Review of Incidence, Outcomes, Treatment, and Prevention
Rita Wilson Dib and others
Open Forum Infectious Diseases, Volume 10, Issue 4, April 2023, ofad166, https://doi.org/10.1093/ofid/ofad166
Published: 25 March 2023
Journal Article
2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
Oscar Morado Aramburo and others
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1742, https://doi.org/10.1093/ofid/ofac492.1742
Published: 15 December 2022
Journal Article
2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
Krithia Srinivasan and others
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1743, https://doi.org/10.1093/ofid/ofac492.1743
Published: 15 December 2022
Journal Article
2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients
Marilyne Daher and others
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1740, https://doi.org/10.1093/ofid/ofac492.1740
Published: 15 December 2022
Journal Article
15. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies
Georgios Angelidakis and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S131–S132, https://doi.org/10.1093/ofid/ofab466.217
Published: 04 December 2021
Journal Article
940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
Fareed Khawaja and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S562–S564, https://doi.org/10.1093/ofid/ofab466.1135
Published: 04 December 2021
Journal Article
922. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis
Amy Spallone and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S552–S553, https://doi.org/10.1093/ofid/ofab466.1117
Published: 04 December 2021
Journal Article
930. Clinically Significant CMV Infections in Patients with Lymphoma or Multiple Myeloma
Joseph Sassine and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S557–S558, https://doi.org/10.1093/ofid/ofab466.1125
Published: 04 December 2021
Journal Article
568. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis
Fareed Khawaja and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Pages S348–S349, https://doi.org/10.1093/ofid/ofaa439.762
Published: 31 December 2020
Journal Article
580. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era
Joseph Sassine and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S355, https://doi.org/10.1093/ofid/ofaa439.774
Published: 31 December 2020
Advertisement
Advertisement